Skip to main content
An official website of the United States government

zelenoleucel

A preparation of allogeneic multi-tumor-associated antigen (MultiTAA)-specific T lymphocytes, with potential immunomodulating and antineoplastic activities. Upon administration, zelenoleucel may target and kill tumor cells expressing the TAAs.
Synonym:allogeneic MultiTAA-specific T lymphocytes MT-401
donor-derived multi-tumor-associated antigen-specific T cells
Code name:MT 401
MT-401
Search NCI's Drug Dictionary